Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Margarita, Jimenez Jambrina"'
Autor:
Maria Isabel Mata Vazquez, Alfonso Muriel, Maria José Requena, Margarita Jimenez Jambrina, Joaquin Ruiz Aredondo, Jose Ramon Molina Hurtado, Carmen Burgaleta, María del Carmen Fernández Valle, Margarita Fernández de la Mata, Santiago Osorio, Jose Luis Sastre, Luis Felipe Casado Montero, Joaquin Martinez Lopez, David Tallón Pérez, Maria de los Angles Portero, Guiomar Bautista, Maria Soledad Duran Nieto, Pilar López Garrido, Ricardo Sola Garcia, Pilar Cano, Rafael Franco Osorio, Pere Barba Suñol, María Jesús Peñarrubia, Jose Manuel Puerta, Antonio Paz Coll, Maria Victoria Moreno Romero, Carmen Calle, Juan Luis Steegmann, Valentín García-Gutiérrez, Raquel de Paz, Jose Angel Hernandez-Rivas, Begoña Maestro, Pilar Giraldo, María José Sánchez, Manuel Pérez-Encinas
Publikováno v:
American Journal of Hematology. 89:E206-E211
In the latest recommendations for the management of chronic-phase chronic myeloid leukemia suboptimal responses have been reclassified as “warning responses.” In contrast to previous recommendations current guidance advises close monitoring witho
Autor:
Valentin, García-Gutiérrez, Jose Manuel, Puerta, Begoña, Maestro, Luis Felipe, Casado Montero, Alfonso, Muriel, Jose Ramon, Molina Hurtado, Manuel, Perez-Encinas, Maria Victoria, Moreno Romero, Pere Barba, Suñol, Ricardo, Sola Garcia, Raquel, De Paz, Maria Jose, Ramirez Sanchez, Santiago, Osorio, Maria Isabel, Mata Vazquez, Joaquin, Martinez López, Jose Luis, Sastre, Maria de Los Angles, Portero, Guiomar, Bautista, Maria Soledad, Duran Nieto, Pilar, Giraldo, Margarita, Jimenez Jambrina, Carmen, Burgaleta, Joaquin, Ruiz Aredondo, Maria Jesús, Peñarrubia, Maria José, Requena, María Del Carmen, Fernández Valle, Carmen, Calle, Antonio, Paz Coll, Jose Ángel, Hernández-Rivas, Rafael, Franco Osorio, Pilar, Cano, David, Tallón Pérez, Margarita, Fernández de la Mata, Pilar López, Garrido, Juan Luis, Steegmann
Publikováno v:
American journal of hematology. 89(11)
In the latest recommendations for the management of chronic-phase chronic myeloid leukemia suboptimal responses have been reclassified as "warning responses." In contrast to previous recommendations current guidance advises close monitoring without c